You searched for prescription-drugs | Page 57 of 178

Medicare Part D Beneficiaries Who Reach the Catastrophic Coverage Limit Can Expect to Pay More Out-of-Pocket for Their Prescription Drugs Next Year

Oct 11, 2019

News Release

Medicare Part D enrollees with relatively high out-of-pocket expenses can expect see their costs rise in 2020, according to a new KFF analysis. This is mainly due to an increase in how much enrollees will pay out of pocket for their prescription drugs in the Part D benefit coverage gap phase before they qualify for catastrophic coverage. The analysis finds that out-of-pocket drug costs will increase by nearly $400 -- from $2,275 in 2019 to…

KFF Health Tracking Poll: Early 2023 Update On Public Awareness On Abortion and Emergency Contraception

Feb 1, 2023

Feature

Following the FDA approval of retail pharmacies carrying and distributing medication abortion, this poll finds that the public's awareness and knowledge of emergency contraception and medication abortion is still lacking, especially among respondents living in states with full abortion bans.

Health Care’s AI Disruption, Ready or Not

Apr 28, 2026

Podcast

The AI revolution is already here — but what does it mean for patients, clinicians, and health care industry leaders? Eric Larsen, veteran health care strategist and longtime advisor to CEOs across the industry, joins host Chip Kahn for a discussion about why the U.S. health care industry is uniquely exposed to AI-driven disruption and the implications for patients, clinicians, and the health care workforce. Listen to Larsen's take on "the most consequential technology humanity’s…

Medicaid Financial Eligibility in Pathways Based on Old Age or Disability in 2022: Findings from a 50-State Survey

Jul 11, 2022

Issue Brief

This issue brief presents state-level data on Medicaid financial eligibility criteria and adoption of the major non-MAGI pathways as of January 2022. The data were collected from March through May 2022 in KFF’s survey of Medicaid state eligibility officials.

New KFF Survey Finds Abortion Remains Key Issue for Voters with Democrats Holding a Sizeable Edge over Republicans; A Third of Women Say They’ll Only Vote for Someone Who Shares Their Views

May 26, 2023

News Release

Nine months ahead of the first presidential primary of the 2024 election season, many voters, especially women, say candidates’ views on abortion will again be a key issue, and Democrats hold a strong edge over Republicans on the issue, a new KFF Health Tracking Poll finds.Three in 10 registered voters (30%) – and a third of women voters (35%) – say they will only vote for a candidate who shares their views on abortion. This…

State Policies Expanding Access to Behavioral Health Care in Medicaid

Dec 9, 2021

Issue Brief

On KFF’s 21st annual Medicaid budget survey, all responding states reported at least one initiative to expand behavioral health care in Medicaid, including crisis service and other benefit expansions, initiatives to expand telehealth and address equity, and managed care changes.

How Corporate Executives View Rising Health Care Cost and the Role of Government

Apr 29, 2021

Report

This survey of executive decision-makers at over 300 large private employers finds most see rising health costs as a threat to their businesses and believe a broader government role will be necessary to control health costs and ensure coverage.

Federal Medicaid Outlays During the COVID-19 Pandemic

Apr 27, 2021

Issue Brief

This data note analyzes federal Medicaid outlays before and during the COVID-19 pandemic. In the one year since the onset of the pandemic, federal Medicaid outlays totaled $500.8 billion and grew by 19.5%, compared to 6.3% growth in the one year before the pandemic.

Abortion Bans May Limit Access to Certain Drugs Used to Treat Women with Cancer, Autoimmune Diseases, and Ulcers

Nov 17, 2022

News Release

A new KFF analysis finds that women comprise the majority of patients who rely on certain drugs that may be restricted in response to state abortion bans. Following the Supreme Court decision to overturn Roe v. Wade, some women in abortion-banning states have reported that clinicians and pharmacists denied them access to medications like methotrexate and misoprostol that are used to manage chronic conditions but are also used for medication abortions and treatment of ectopic…

Mail Delays Could Affect Mail-Order Prescriptions for Millions of Medicare Part D and Large Employer Plan Enrollees

Aug 20, 2020

Issue Brief

Potential changes in mail service delivery could be a concern for people who receive prescription drugs from mail-order pharmacies. To understand who may be most affected by delays in the delivery of prescription drugs, we analyzed use of mail order in Medicare Part D and large group employer plans, and identified the therapeutic classes and specific drugs with the highest volume of fills by mail-order pharmacies in each market.

Topics

Policy Research

Polling

Health News

Data & Features

For Media

About

Search

Filter